# A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease

> **NCT01484990** · PHASE1 · COMPLETED · sponsor: **AbbVie** · enrollment: 19 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Levodopa-Carbidopa

## Key facts

- **NCT ID:** NCT01484990
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2017-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01484990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01484990, "A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT01484990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*